PA
AIMT

Parallel Advisors’s Aimmune Therapeutics AIMT Stock Holding History

Parallel Advisors’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-101
Closed -$3K – 2823
2020
Q3 		$3K Sell
101
-228
-69% -$4.86K ﹤0.01% 2247
2020
Q2 		$5K Hold
329
– – ﹤0.01% 1990
2020
Q1 		$4K Buy
+329
New +$8.41K ﹤0.01% 1999

Parallel Advisors's AIMT Position: Q4 2020 in Review

Parallel Advisors sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 101 shares — an estimated $3K sold.

Parallel Advisors first reported a position in AIMT in Q1 2020 and held it in 3 quarters. The position peaked at $5K in Q2 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Parallel Advisors reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Parallel Advisors sold 101 Aimmune Therapeutics shares in Q4 2020, an estimated $3K.
  • Parallel Advisors first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 3 quarters.
  • Parallel Advisors's Aimmune Therapeutics position peaked at $5K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.